Logo
Logo

About Metoprolol Succinate API

Product
  • Therapeutic CategoryCardiovascular

  • CAS Number

    98418-47-4

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, Canada DMF, China DMF

Mechanism of Action

Several possible mechanisms have been proposed:

 

  • Competitive antagonism of catecholamine at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output;
  • A central effect leading to reduced sympathetic outflow to the periphery; and
  • Suppression of renin activity.

 

Indication

 

  • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
  • Angina Pectoris.
  • Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin.

 

Related APIs

Amlodipine Besylate

Cardiovascular

arrow

Apixaban

Cardiovascular

arrow

Atorvastatin Calcium (Amorphous And Form 1)

Cardiovascular

arrow

Bempedoic Acid

Cardiovascular

arrow

Clopidogrel Bisulfate (Form 1)

Cardiovascular

arrow

Clopidogrel Bisulfate (Form 2)

Cardiovascular

arrow

Dabigatran Etexilate Mesylate

Cardiovascular

arrow

Doxazosin Mesylate

Cardiovascular

arrow

Ezetimibe

Cardiovascular

arrow

Fondaparinux Sodium

Cardiovascular

arrow

Lacidipine

Cardiovascular

arrow

Losartan Potassium

Cardiovascular

arrow

Mavacamten

Cardiovascular

arrow

Metoprolol Succinate

Cardiovascular

arrow

Ramipril

Cardiovascular

arrow

Rivaroxaban

Cardiovascular

arrow

Sacubitril / Valsartan

Cardiovascular

arrow

Tafamidis Free Acid

Cardiovascular

arrow

Tafamidis Meglumine

Cardiovascular

arrow

Ticagrelor

Cardiovascular

arrow

Treprostinil

Cardiovascular

arrow

Treprostinil Olamine

Cardiovascular

arrow

Valsartan

Cardiovascular

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.